Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis. [electronic resource]
Producer: 20050616Description: 567-75 p. digitalISSN:- 0195-668X
- Abciximab
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Aspirin -- therapeutic use
- Clopidogrel
- Coronary Angiography
- Coronary Disease -- diagnostic imaging
- Creatine Kinase -- blood
- Creatine Kinase, MB Form
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Isoenzymes -- blood
- Logistic Models
- Male
- Middle Aged
- Neovascularization, Pathologic
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Premedication
- Recurrence
- Stents
- Survival Rate
- Thrombosis -- prevention & control
- Ticlopidine -- analogs & derivatives
- Troponin T -- blood
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.